Abstract: A sensor includes: a needle member defining a hollow portion, wherein the needle member comprises a peripheral wall, and a through hole extends through the peripheral wall; an elongated detection member positioned in the hollow portion and extending along a longitudinal direction of the needle member; and at least one protruding portion that protrudes radially inward from the peripheral wall and restricts movement of the detection member in a radial direction.

Abstract: An electronic device according to an aspect of the present disclosure includes a touch screen. The electronic device includes a communication interface that may receive, from a touch pen, a pulse wave signal of a user which is measured from a finger of the user by the touch pen while the touch pen is placed on the touch screen. The electronic device includes a processor that may determine whether a measurement posture of the user is appropriate based on whether the finger touches the touch screen, and in response to determining that the user's measurement posture is appropriate, estimate bio-information of the user based on the received pulse wave signal.

Abstract: In a method and apparatus for measuring an alcohol concentration, a blood alcohol concentration of a driver is rapidly and precisely measured by selecting a plurality of wavelengths based on the absorbance for blood components exerting an influence on the measurement result of the blood alcohol concentration and by measuring the blood alcohol concentration of the driver based on the absorbance detected with respect to a physical body of a user by using the plurality of selected wavelengths. Starting of the vehicle is controlled based on the blood alcohol concentration of the driver, which is measured by measuring the alcohol concentration.

Abstract: A device and method for spectrum analysis in which differences among skin spectra are quantitatively analyzed, and a blood glucose measurement device are provided. The device for spectrum analysis includes an obtainer configured to acquire a plurality of skin spectra; and a processor configured to generate a plot of difference degree of spectra which represents differences among the acquired plurality of skin spectra, and determine whether the plurality of skin spectra are appropriate for blood glucose measurement based on the plot of difference degree of spectra.

Abstract: A computer system for simultaneously sampling multiple light channels is configured to emit a first pulse-oximetry light signal from a first light source and to emit a second pulse-oximetry light signal from a second light source. The computer system then captures a combined pulse-oximetry signal from both the first pulse-oximetry light signal and the second pulse-oximetry light signal simultaneously at a photoreceptor sensor. The computer system identifies information within the combined pulse-oximetry signal, wherein the first light source and the second light source capture different attributes of the information.

Abstract: The invention comprises a method and apparatus for selecting optical pathways sampling a common tissue layer, such as the dermis, of a person for analysis in a noninvasive analyte property determination systemy, comprising the steps of: probing skin with a range of illumination zone-to-detection zone distances with at least two wavelength ranges, which optionally overlap, and selecting, using a metric, illumination zone-to-detection zone distances having mean optical pathways probing the common tissue layer, such as without the mean optical pathways entering the subcutaneous fat layer of the person. Optionally, the skin tissue layers are modulated and/or treated via tissue displacement before and/or during data collection.

Abstract: A monitoring device configured to be attached to a subject includes a photoplethysmography (PPG) sensor configured to measure physiological information from the subject, a blood flow stimulator, and a processor configured to process signals from the PPG sensor to determine a signal-to-noise level of the signals. In response to a signal-to-noise level determination, the processor is configured to instruct the blood flow stimulator to increase blood perfusion at a location where the PPG sensor is attached to the subject. The signal-to-noise level determination may be a determination that the signal-to-noise level is below a threshold level. The blood flow stimulator may be a heating element or light source configured to heat the location of the subject.

Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

Abstract: This invention is a wearable ring of optical biometric sensors comprising an arcuate array of light emitters and light receivers which is configured to collectively span at least half of the circumference of a person's wrist, finger, or arm. Light energy from the light emitters which has passed through the person's body tissue and/or has been reflected from the person's body tissue is analyzed in order to measure biometric parameters such as the person's oxygenation level, hydration level, glucose level, pulse rate, heart rate variability, and/or blood pressure.

Abstract: A method and apparatus for monitoring a subject's autoregulation function state is provided. The method includes: a) continuously sensing a tissue region of the subject with a tissue oximeter, the sensing producing first signals, and determining frequency domain tissue oxygen parameter values; b) continuously measuring a blood pressure level of the subject using a blood pressure sensing device, the measuring producing second signals, and determining frequency domain blood pressure values; c) determining a coherence value indicative of the subject's autoregulation state in each of a plurality of different frequency bands; and d) determining a peak coherence value indicative of the subject's autoregulation state based on the determined coherence value from each of the plurality of different frequency bands.

Abstract: A method, system, apparatus, and/or device to determine a condition of a user using a wearable device with a miniaturized spectrometer. The method, system, apparatus, and/or device may include: a band configured to extend at least partially around a body part of a user, the body part comprising an internal feature within the body part; a light source embedded in the band, where the light source is configured to emit light into the body part as the user wears the band; a collimator; an optical filter; and an optical sensor, where the collimator, optical sensor, or the optical filter are arranged together to form a stack embedded in the band.

Abstract: A sleep apnea syndrome symptom improvement aid 1 includes a sandwiching target 10 sandwiched by front teeth of a patient, a tongue presser 20 extending from the sandwiching target 10 to the vicinity of the soft palate of the patient and including an elastic body configured to press the tongue, and a detector 30 configured to detect at least one of a vital sign or a salivary component of the patient.

Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.

Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

Abstract: An apparatus for estimating bio-information of an object of interest may include a processor configured to obtain a plurality of pulse wave signals of an object via a plurality of channels, determine a plurality of oxygen saturation values corresponding to the plurality of channels based on the plurality of pulse wave signals, select a channel to be used for estimating the bio-information of the object of interest from among the plurality of channels based on the plurality of oxygen saturation values, and estimate the bio-information of the object of interest based on a pulse wave signal corresponding to the selected channel.

Abstract: Provided is a blood glucose measurement device and method. The blood glucose measurement device may determine a blood glucose unit to be provided to a user based on a user input and a region in which the device is positioned, and provide blood glucose data to the user using the determined blood glucose unit through a display.

Abstract: A monitoring device configured to be attached to a subject includes a photoplethysmography (PPG) sensor configured to detect/measure physiological information from the subject, and a processor configured to process the physiological information to detect subject stress, and to determine an origin of the subject stress. The processor can determine the origin of the subject stress by increasing a sampling rate of the PPG sensor to collect higher acuity physiological information. The processor also can determine the origin of the subject stress by processing data from the PPG sensor to determine whether the subject is likely to have atrial fibrillation. In response to determining that the subject is likely to have atrial fibrillation, the processor can increase a frequency of pulsing of an optical emitter of the PPG sensor and/or increase a sampling rate of the PPG sensor to collect higher acuity data for diagnosing that atrial fibrillation is truly occurring.

Abstract: The present invention relates to a sensor device and method for obtaining physiological information of a subject. The sensor device comprises a PPG sensor (20), a motion sensor (30) and a device (10) for obtaining physiological information of the subject. The device comprises a processing unit (13) for generating an output signal carrying physiological information by (i) modulating the motion reference signal on a carrier signal of the first set of carrier signals or on a second carrier signal orthogonal to the first set of carrier signals to obtain a modulated signal and combining the modulated signal with the modulated PPG signals to obtain the output signal or (ii) demodulating the modulated PPG signals, performing artifact-reduction on the demodulated PPG signals using the motion reference signal to obtain artifact-reduced PPG signals and modulating the artifact-reduced PPG signals on the first set of carrier signals to obtain the output signal.

Abstract: A device, system and method of non-invasive monitoring of physiological measurements of a subject are disclosed. The method may include: emitting light beams towards skin of the subject, with at least one light source having at least one predetermined polarization, wherein the light beams are emitted at an angle 0°??<90° relative to the normal to the skin surface of the subject; sensing light beams with at least one light sensor positioned at a predetermined distance from the at least one light emitting source; filtering out signals corresponding to detected light beams based on the at least one predetermined polarization of the at least one light source; and determining at least one physiological signal, based on the sensed light beams after filtering. The sensed light beams may pass through at least one of epidermis, dermis, subcutaneous tissue and blood vessel of the subject.